<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02604121</url>
  </required_header>
  <id_info>
    <org_study_id>12 045 03</org_study_id>
    <nct_id>NCT02604121</nct_id>
  </id_info>
  <brief_title>Cytological Screening for Early Diagnosis of Precancerous or Cancerous Lesions of Oral Cavity</brief_title>
  <acronym>Cytobuccale</acronym>
  <official_title>Interest of Cytological Screening for Early Diagnosis of Precancerous or Cancerous Lesions of Oral Cavity by Transepithelial Brushing in Liquid-based</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective study of diagnosis validation of a cytological technique. 200 patients with oral
      cavity cancerous and precancerous lesions will be enrolled.

      A cytological sample of the lesion will be performed by transepithelial brushing ( Orcellex®
      Rovers brush) in cytology liquid-based technology (methode ThinPrep 2000 (Hologic®)). A
      microscopic double blind reading will be performed. A biopsy sampling will be carried out in
      accordance with current strategy of screening. The brushing diagnosis quality will be
      compared to the biopsy which is the gold standard.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic validity of lesion (Bethesda system, 2001)</measure>
    <time_frame>baseline</time_frame>
    <description>Diagnostic validity (specificity and sensibility, the classification of lesions is performed according Bethesda system, 2001 and the reference is the histology of biopsy of lesion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic validity - predictive value (positive and negative)</measure>
    <time_frame>baseline</time_frame>
    <description>Calculation of predictive value (positive and negative) of cytology / the reference is histology of biopsy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility of cytology</measure>
    <time_frame>Baseline</time_frame>
    <description>sample rate not satisfactory= hemorrhage hiding the cells of interest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility of cytology</measure>
    <time_frame>Baseline</time_frame>
    <description>sample rate not satisfactory : low cellularity of the material</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reproducibility intra and inter observers (coefficient of kappa de cohen)</measure>
    <time_frame>Baseline</time_frame>
    <description>reproducibility intra and inter observers of cytology interpretation (kappa de cohen)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Mouth Neoplasms</condition>
  <arm_group>
    <arm_group_label>transepithelial brushing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>transepithelial brushing in liquid-based technology + biopsy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Orcellex® Rovers brush</intervention_name>
    <description>transepithelial brushing</description>
    <arm_group_label>transepithelial brushing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  one or several cancerous or pre-cancerous lesions of oral cavity newly diagnosed or
             detected during a follow-up visit

        Exclusion Criteria:

          -  pregnant or lactating women

          -  patients under juridical protection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laetitia COLIN-LACOSTE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laetitia COLIN-LACOSTE, MD</last_name>
    <phone>33-5 61 32 22 13</phone>
    <email>colin.l@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laura BOGDANOVITCH</last_name>
    <phone>33-561778490</phone>
    <email>bogdanovitch.l@chu-toulouse.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laetitia COLIN-LACOSTE, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2015</study_first_submitted>
  <study_first_submitted_qc>November 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2015</study_first_posted>
  <last_update_submitted>March 12, 2017</last_update_submitted>
  <last_update_submitted_qc>March 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>oral cavity</keyword>
  <keyword>cancerous and precancerous lesions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mouth Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

